Plasma clearance of chicken and human insulin-like growth factor-I and their association with circulating binding proteins in chickens.
We have investigated the clearance of 125I-labelled chicken and recombinant human insulin-like growth factor-I (IGF-I) from the circulation of chickens as well as the role that IGF-binding proteins play in this process. Analysis of plasma samples by high-performance liquid chromatography (HPLC) neutral gel permeation on a TSK G3000SW column indicated that the i.v. injected radioactivity was rapidly partitioned between at least three pools. Most of the radioactivity occurred in a complex with binding protein(s), while smaller amounts of radioactivity chromatographed in the free IGF-I peak or appeared as low molecular weight degradation products. The labelled chicken and human IGF-I were rapidly cleared during the first 90 min. The calculated half-life for total labelled IGF-I during this period was 54 min for the chicken tracer and 33 min for the human tracer. The clearance was monitored for 10 h during which the human tracer continued to be cleared more rapidly than the chicken tracer. The proportion of radioactivity appearing as low molecular weight degradation products increased with time. Acid gel permeation and reverse-phase HPLC of the binding protein-associated radioactivity demonstrated that the labelled IGF-I bound was intact IGF-I. Sephadex G-200 gel permeation chromatography of chicken plasma samples at pH 7 x 4 showed that the binding protein complex labelled in vivo with chicken IGF-I tracer had a molecular mass of 55 kDa. Furthermore, the tracer associated with the binding protein coeluted with the major peak of endogenous IGF-I, suggesting that the tracer was bound to the physiologically relevant binding protein.(ABSTRACT TRUNCATED AT 250 WORDS)
Francis
G L
GL
CSIRO Division of Human Nutrition, Adelaide, South Australia.
McMurtry
J P
JP
Johnson
R J
RJ
Ballard
F J
FJ
D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism*; D002645:Chickens / Q000378:metabolism*; D002850:Chromatography, Gel; D006207:Half-Life; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000493:pharmacokinetics*; D008297:Male; D008657:Metabolic Clearance Rate; D011994:Recombinant Proteins / Q000493:pharmacokinetics; D013002:Somatomedins / Q000493:pharmacokinetics*
D002352:Carrier Proteins; D011994:Recombinant Proteins; D013002:Somatomedins; D007334:Insulin-Like Growth Factor I